13F filer · CIK 1780067
Atlas Venture Associates IX, LLC
BOSTON, MA · filing since Q4 2020 · last filing Feb 11, 2021
Reported value
$631.0M
Positions
7
New / sold out
7 / 0
Added / reduced
0 / 0
Turnover
–
buys $631.0M · sells $0
Top-10 weight
100.0%
No 13F for Q3 2020, so every position this quarter shows as new.
Biggest buys vs Q3 2020
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | SKILLZ INC | +23,284,403 | – | +$465.7M |
| New | INTELLIA THERAPEUTICS INC | +1,615,321 | – | +$87.9M |
| New | SURFACE ONCOLOGY INC | +2,945,453 | – | +$27.2M |
| New | SPERO THERAPEUTICS INC | +1,376,968 | – | +$26.7M |
| New | COGENT BIOSCIENCES INC | +916,196 | – | +$10.3M |
| New | SNAP INC | +150,160 | – | +$7.5M |
| New | SYNLOGIC INC | +2,651,963 | – | +$5.7M |
Biggest sells vs Q3 2020
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q4 2020
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SKILLZ INCCOM | 23,284,403 | $465.7M | 73.80% |
| 2 | INTELLIA THERAPEUTICS INCCOM | 1,615,321 | $87.9M | 13.93% |
| 3 | SURFACE ONCOLOGY INCCOM | 2,945,453 | $27.2M | 4.31% |
| 4 | SPERO THERAPEUTICS INCCOM | 1,376,968 | $26.7M | 4.23% |
| 5 | COGENT BIOSCIENCES INCCOM | 916,196 | $10.3M | 1.63% |
| 6 | SNAP INCCL A | 150,160 | $7.5M | 1.19% |
| 7 | SYNLOGIC INCCOM | 2,651,963 | $5.7M | 0.91% |